Carecloud Inc Stock Price, News & Analysis

CareCloud (NASDAQ: CCLD) held its 2025 Annual Shareholders' Meeting on May 27, 2025, where shareholders approved three key proposals. The meeting resulted in the re-election of three board members - Anne Busquet, Bill Korn, and Lawrence Sharnak - for two-year terms. Shareholders also approved the compensation package for named executive officers and the appointment of Rosenberg Rich Baker Berman, P.A. as the company's independent registered public accounting firm for the fiscal year 2025.

The re-elected board members bring significant experience: Busquet has over 30 years of executive experience with American Express and Interactive Corp, Korn previously served as CareCloud's CFO for 10 years until October 2023, and Sharnak held various senior leadership roles during his 30-year tenure at American Express.

CareCloud (NASDAQ: CCLD) has been named the "Top Healthcare IT Pick for 2025" by Maxim Group, highlighting the company's AI strategy and strong financial performance. Maxim Group's analyst Allen Klee emphasized CareCloud's attractive valuation, noting it trades at a 2026 EV/EBITDA multiple of 5.0x, significantly below the peer group average of 12.5x.

The company reported impressive Q1 2025 results with 52% year-over-year adjusted EBITDA growth. CareCloud's recently launched AI Center of Excellence, starting with 50 AI professionals and planning to expand to 500 by year-end, demonstrates its commitment to AI integration. The company's AI suite includes tools like cirrusAI Notes, cirrusAI Appeals, and cirrusAI Voice, positioning CareCloud as a leader in healthcare AI solutions.

CareCloud (CCLD) has announced monthly cash dividend payments for its Series A and Series B Preferred Stock for May and June 2025. Both series carry an 8.75% annual dividend rate on a $25.00 per share liquidation preference. The monthly dividend for both series is set at $0.18229 per share. Series A holders will receive an additional payment of $0.04688 per share, reflecting a 2.25% adjustment from a previous 11% dividend rate. The dividends will be paid on June 16, 2025, and July 15, 2025, with respective record dates of May 31 and June 30, 2025.

CareCloud (Nasdaq: CCLD) has launched its AI Center of Excellence (AI CoE), starting with 50 AI engineers, data scientists, and healthcare experts, with plans to expand to 500 AI professionals by Q4 2025. The initiative aims to become the world's largest dedicated healthcare AI center.

Operating under a dual-shore model, the self-funded AI CoE leverages CareCloud's 25 years of clinical and financial data to develop proprietary healthcare AI solutions. The center focuses on developing intelligent models for clinical workflows, revenue cycle processes, and decision support, while streamlining operations through automation.

Key focus areas include:

• Proprietary healthcare AI model development
• Automation of clinical documentation and claims management
• Predictive analytics for reimbursement risks
• AI-driven patient engagement enhancement
• Integration of AI across EHR and RCM platforms

CareCloud (Nasdaq: CCLD), a healthcare technology and generative AI solutions provider, has scheduled its first quarter 2025 financial results announcement for May 6, 2025, before market opening. The company will host an investor conference call at 8:30 a.m. Eastern Time on the same day.

Investors can access the live webcast and presentation slides at ir.carecloud.com/events, or join via audio-only option by dialing 201-389-0920. A replay will be available approximately three hours after the call's conclusion, accessible through the same link or by dialing 412-317-6671 with access code 13753440.

CareCloud (Nasdaq: CCLD) has announced its participation in the 15th Annual LD Micro Invitational at the Westin Grand Central Hotel in New York on April 9-10, 2025. The healthcare technology solutions provider will deliver its corporate presentation on April 10, 2025 at 3:30 p.m. ET.

During the event, management will showcase the company's:

• Recent developments and innovative solutions
• Strategic growth initiatives
• Two recent acquisitions
• Conversion of Series A preferred stock
• Significant profitability growth throughout 2024

The team will also engage in one-on-one meetings with institutional and individual investors to discuss growth opportunities and value creation strategies.

CareCloud (NASDAQ: CCLD) has announced the acquisition of RevNu Medical Management, an audiology-focused revenue cycle management company based in Westminster, California. This marks CareCloud's second acquisition in 31 days, following the MesaBilling deal.

RevNu's founder Clay Gililland, who owns over 30 hearing health clinics in Southern California, will integrate with CareCloud to leverage their technology and automation capabilities. Daniel Davis, former RevNu CEO, will lead CareCloud's new hearing healthcare division as President.

The acquisition targets the U.S. audiology market, which includes approximately 24,000 employed audiologists and hearing aid specialists, with annual hearing aid spending exceeding $5 billion. The segment remains minimally penetrated by outsourced RCM vendors. The acquisition is expected to be accretive within 90 days, with consideration paid quarterly based on retained revenue.

CareCloud (Nasdaq: CCLD) announced an expanded partnership with Alpine Ear, Nose & Throat PC, a Colorado-based otolaryngology group. Following their existing revenue cycle management (RCM) collaboration, Alpine ENT has implemented CareCloud FrontDesk Assist, a front-office solution aimed at streamlining operations.

Alpine ENT, with 24 providers across three Northern Colorado locations, reported improvements in operational efficiency since implementing FrontDesk Assist, including reduced patient wait times and streamlined appointment scheduling. The solution supports critical front-office functions such as referral management, surgery estimates, and prior authorizations.

The practice, which offers ENT services, audiology, vestibular therapy, and allergy care, has experienced measurable gains in productivity and patient engagement through this expanded partnership. FrontDesk Assist is now available nationwide to healthcare practices across all specialties.